Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. (Q40488388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

A I Schafer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

Texas Heart Institute Journal

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

90-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

4 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=325410

Novel antithrombotic therapeutics targeted against platelet glycoprotein IIb/IIIa

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=325410

Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=325410

GPIIb-IIIa: the responsive integrin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=325410

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=325410

Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation

25 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9205981

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibitors of platelet glycoprotein IIb/IIIa receptors. Will they be useful when given chronically?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9205981

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/9205981

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9205981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

9205981

1 reference